Impact on clinical biomarkers, immune recovery, and HIV reservoir dynamics of switching to EVG/c/FTC/TAF versus maintaining a non-INSTI-based regimen in virologically suppressed individuals [0.03%]
switch to EVG/c/FTC/TAF对临床生物标志物、免疫恢复和病毒库动力学的影响：一项与继续使用非整合酶抑制剂方案对比的队列研究
Yi Zhang,Hui-Huang Huang,Bing Song et al.
Yi Zhang et al.
Background: Integrase Strand Transfer Inhibitors (INSTIs) have emerged as the preferred first-line antiretroviral therapy (ART) regimen globally, primarily due to their superior efficacy and favorable safety profile. Howe...
Identifying Malaria Hotspots Regions in Ghana Using Bayesian Spatial and Spatiotemporal Models [0.03%]
基于贝叶斯空间模型和时空模型识别加纳的疟疾高发区
Abdul-Karim Iddrisu,Dominic Otoo,Gordon Hinneh et al.
Abdul-Karim Iddrisu et al.
Background: Malaria remains a significant public health concern in Ghana, with varying risk levels across different geographical areas. Malaria affects millions of people each year and imposes a substantial burden on the ...
Physical Diagnostic Examinations of Cavernous Pulmonary Tuberculosis in the 19th and 21st Centuries [0.03%]
19世纪和21世纪海绵状肺结核的物理诊断检查
Volodymyr Berezutskyi
Volodymyr Berezutskyi
Fu-Sheng Wang,Linqi Zhang
Fu-Sheng Wang
Even a Small Stride Can Have a Significant Impact: Enhancing the Effectiveness of Influenza Vaccines [0.03%]
小步也能走大路——提升流感疫苗效力
Weixiao Wang,Jingxin Li
Weixiao Wang
Genetic Basis for Mucormycosis Progression in COVID-19 Patients: From Susceptibility to Severity [0.03%]
COVID-19患者毛霉病的遗传基础：从易感性到严重程度
Jethendra Kumar Muruganantham,Ramakrishnan Veerabathiran
Jethendra Kumar Muruganantham
The dynamics of COVID-19 and mucormycosis reveal a complex interplay of genetic factors that influence the susceptibility, severity, and immune responses. COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exh...
Prevention and Treatment of Mycoplasma pneumoniae Requires Long-term Attention [0.03%]
预防和治疗支原体肺炎任重道远
Dawei Zhang,Zhaomin Feng,Quanyi Wang
Dawei Zhang
Combatting Antibiotic Resistance: Regulatory Exclusivities for New Antibiotic Development in the United States and Europe [0.03%]
美国和欧洲促进新抗生素研发的监管 exclusivities 抗击抗生素抗药性问题
Vivek Reddy Murthannagari,Vaishnavi Parimala Thumpati,Ganesh Gnk
Vivek Reddy Murthannagari
Antimicrobial resistance is a global concern that has led to millions of deaths worldwide. Genetic changes occur naturally in pathogens such as viruses, bacteria, parasites, and fungi. To overcome these concerns, there is a need to develop ...
Challenges and Strategies for Influenza Response After COVID-19 Pandemic [0.03%]
新冠肺炎大流行后的流感应对挑战与策略分析
Jiaying Yang,Shuxia Lin,Yuelong Shu
Jiaying Yang
Adenovirus F40/41 Gastroenteritis-Associated Emphysematous Gastritis: A Case Report [0.03%]
腺病毒F40/41胃肠炎相关气囊胃炎：病例报告
Maulik K Lathiya,Abigail T La Nou,Maria E Linnaus et al.
Maulik K Lathiya et al.
Emphysematous gastritis (EG) is a rare form of gastritis characterized by gastric wall pneumatosis. It is associated with a high mortality rate. Our case report describes a patient with a history of atrial fibrillation treated with apixaban...